Townsend & Associates’s Edwards Lifesciences EW Stock Holding History

Townsend & Associates’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.3M	Buy	203,401 +3,935	+2%	+$330K	1.47%	27
2026 Q1	$16.3M	Buy	199,466 +5,809	+3%	+$479K	1.4%	31
2025 Q4	$16.4M	Buy	193,657 +3,323	+2%	+$273K	1.46%	29
2025 Q3	$14.2M	Buy	190,334 +6,158	+3%	+$481K	1.35%	34
2025 Q2	$14.7M	Sell	184,176 -30,623	-14%	-$2.28M	1.46%	26
2025 Q1	$14.9M	Buy	214,799 +34,048	+19%	+$2.44M	1.55%	28
2024 Q4	$12.6M	Buy	180,751 +5,773	+3%	+$404K	1.3%	35
2024 Q3	$12.4M	Buy	174,978 +8,441	+5%	+$613K	1.27%	35
2024 Q2	$10.4M	Buy	166,537 +3,960	+2%	+$351K	1.15%	38
2024 Q1	$14.3M	Buy	162,577 +1,867	+1%	+$157K	1.66%	29
2023 Q4	$11.7M	Buy	160,710 +84,306	+110%	+$5.87M	1.46%	33
2023 Q3	$4.71M	Buy	76,404 +34,123	+81%	+$2.74M	1%	35
2023 Q2	$3.88M	Buy	42,281 +18,623	+79%	+$1.62M	1%	36
2023 Q1	$2.08M	Buy	23,658 +15,287	+183%	+$1.2M	0.84%	45
2022 Q4	$650K	Buy	+8,371	New	+$645K	0.32%	67

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

Townsend & Associates's EW Position: Q2 2026 in Review

Townsend & Associates increased its Edwards Lifesciences (EW) stake by 2% in Q2 2026, buying an estimated $330K and bringing the position to 203,401 shares worth $17.3M. The position accounts for 1.47% of the portfolio, ranked #27.

Townsend & Associates first reported a position in EW in Q4 2022 and has held it in 15 quarters since. 563 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Townsend & Associates held 203,401 shares of Edwards Lifesciences worth $17.3M as of Q2 2026.
Townsend & Associates bought 3,935 Edwards Lifesciences shares in Q2 2026, an estimated $330K.
Edwards Lifesciences made up 1.47% of Townsend & Associates's portfolio in Q2 2026, its #27 holding.
Townsend & Associates first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 15 quarters since.
563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Townsend & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.